Interestingly, analysis of the Genomics of Drug Sensitivity in Cancer database [42], a publicly available IC50 dataset of 147 anticancer agents on over 1000 tumor cell lines, revealed that PLX4720 was one of the seven drugs that show increased effectiveness toward cancers that have genomic alterations of the Rb gene [43]. Here, RB1 is linked to neoplasm.